Loading financials from SEC filings…
IT services · Technology · Fiscal year ends Jan 29
Science Applications International reported revenue of $7.3B in the fiscal year ended Jan 2026, down 2.9% from the year before. Operating income was $521M, an operating margin of 7.2%, and net income was $358M. Operating cash flow of $609M less capital expenditure of $32M left free cash flow of $577M. Net debt was $2.3B.
Ranks among the 36 it services companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Jan 2022 | Feb 2023 | Feb 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 7,394 | 7,704 | 7,444 | 7,479 | 7,262 |
| Cost of revenue | 6,535 | 6,816 | 6,572 | 6,587 | 6,390 |
| Gross profit | 859 | 888 | 872 | 892 | 872 |
| Research & development | 4.0 | 1.0 | 4.0 | 12.0 | 13.0 |
| Selling, general & admin | 344 | 374 | 373 | 339 | 350 |
| Operating income | 462 | 501 | 741 | 563 | 521 |
| Net interest incomeBanks | −105 | −118 | −120 | −126 | – |
| Interest expense | 105 | 120 | 120 | 126 | 128 |
| Pre-tax income | 358 | 375 | 620 | 428 | 387 |
| Income tax | 79.0 | 72.0 | 143 | 66.0 | 29.0 |
| Net income | 277 | 300 | 477 | 362 | 358 |
| Diluted EPS | 4.77 | 5.38 | 8.88 | 7.17 | 7.70 |
| Diluted shares | 58.1 | 55.8 | 53.7 | 50.5 | 46.5 |
| Fiscal year | Jan 2022 | Feb 2023 | Feb 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|
| Cash & equivalents | 106 | 109 | 94.0 | 56.0 | 182 |
| Receivables | 1,015 | 936 | 914 | 1,000 | 853 |
| Inventory | 64.0 | 71.0 | 3.0 | – | – |
| Current assets | 1,263 | 1,197 | 1,131 | 1,154 | 1,179 |
| Net PP&E | 100 | 92.0 | 91.0 | 104 | 110 |
| Goodwill | 2,913 | 2,911 | 2,851 | 2,851 | 2,944 |
| Total assets | 5,746 | 5,543 | 5,314 | 5,246 | 5,354 |
| Payables | 612 | 624 | 567 | 631 | 500 |
| Deferred revenue | – | – | – | 38.0 | 41.0 |
| Current liabilities | 1,352 | 1,126 | 1,158 | 1,396 | 982 |
| Short-term debt | 148 | 31.0 | 77.0 | 313 | 19.0 |
| Long-term debt | 2,370 | 2,343 | 2,022 | 1,907 | 2,468 |
| Total liabilities | 4,117 | 3,839 | 3,529 | 3,669 | 3,854 |
| Shareholders' equity | 1,619 | 1,694 | 1,785 | 1,577 | 1,500 |
| Backlog (remaining obligations) | 5,300 | 5,000 | – | – | – |
| Fiscal year | Jan 2022 | Feb 2023 | Feb 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|
| Operating cash flow | 518 | 532 | 396 | 494 | 609 |
| Capital expenditure | 36.0 | 25.0 | 27.0 | 36.0 | 32.0 |
| Free cash flow | 482 | 507 | 369 | 458 | 577 |
| Depreciation & amortisation | 37.0 | 32.0 | 26.0 | 25.0 | 30.0 |
| Stock-based compensation | 46.0 | 48.0 | 68.0 | 53.0 | 64.0 |
| Acquisitions | 255 | 0.0 | 0.0 | 0.0 | 203 |
| Share buybacks | 226 | 267 | 382 | 558 | 445 |
| Dividends paid | 86.0 | 83.0 | 79.0 | 75.0 | 70.0 |
| Dividend per share | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 |
| Fiscal year | Jan 2022 | Feb 2023 | Feb 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 4.2% | −3.4% | 0.5% | −2.9% |
| Operating income growth (YoY) | – | 8.4% | 47.9% | −24.0% | −7.5% |
| EPS growth (YoY) | – | 12.8% | 65.1% | −19.3% | 7.4% |
| Gross margin | 11.6% | 11.5% | 11.7% | 11.9% | 12.0% |
| Operating margin | 6.2% | 6.5% | 10.0% | 7.5% | 7.2% |
| Net margin | 3.7% | 3.9% | 6.4% | 4.8% | 4.9% |
| Return on equityBlank when equity is negative | 17.1% | 17.7% | 26.7% | 23.0% | 23.9% |
| ROCEEBIT ÷ (assets − current liabilities) | 10.5% | 11.3% | 17.8% | 14.6% | 11.9% |
| Free cash flow margin | 6.5% | 6.6% | 5.0% | 6.1% | 7.9% |
| Cash conversion (CFO ÷ net income) | 1.87x | 1.77x | 0.83x | 1.36x | 1.70x |
| Receivable days | 50 | 44 | 45 | 49 | 43 |
| Inventory days | 4 | 4 | 0 | – | – |
| Payable days | 34 | 33 | 31 | 35 | 29 |
| Interest cover | 4.40x | 4.17x | 6.17x | 4.47x | 4.07x |
| Debt ÷ equity | 1.56x | 1.40x | 1.18x | 1.41x | 1.66x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 2,412 | 2,265 | 2,005 | 2,164 | 2,305 |
| Current ratio | 0.93x | 1.06x | 0.98x | 0.83x | 1.20x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.